Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.13.13 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Fruzsina R Papp and 9 co-authors. Institution: Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Major MEDLINE topics: Hyaluronic Acid, Cell Differentiation, Myofibroblasts, Graves Ophthalmopathy. Cited 6 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To study the impact of myofibroblast differentiation (MD) on hyaluronan (HA) turnover in orbital fibroblasts (OFs) focusing on the expression of its key enzymes and their potential implications in the pathogenesis of thyroid eye disease (TED).
Methods
Primary cultures of OFs were established from tissue samples (TED OFs, n = 4; non-TED OFs, n = 5). MD was induced by TGF-β1 (5 ng/mL). Measurements were performed after 24- and 72-hour treatments. The proliferation rate was determined by 5-bromo-2'-deoxyuridine (BrdU) incorporation. HA level and size were measured using an aggrecan-based ELISA-like method and agarose gel electrophoresis, respectively. mRNA expressions of myofibroblast markers and enzymes with a role in HA metabolism were determined using real-time PCR.
Results
Upregulation of type I collagen alpha1 chain, alpha-smooth muscle actin, and fibronectin indicated that OFs underwent MD after stimulation by TGF-β. After 72 hours, proliferation of untreated cultures declined, but it remained higher in myofibroblasts. Pericellular HA content, but not HA in the supernatant of myofibroblasts, increased compared to untreated cells. TGF-β was a potent stimulator of hyaluronan synthase 1 (HAS1) expression. The expression of hyaluronidase-1 and cell migration-inducing protein (CEMIP) diminished following MD, whereas the expression of transmembrane protein 2, the regulator of HA catabolism through CEMIP, was elevated. The size distribution of HA shifted toward a high-molecular-weight form following treatment with TGF-β.
Conclusions
OFs undergoing MD are characterized by decreased HA turnover as a consequence of the inhibition of hyaluronidases and HAS1 induction. Our results suggest that hyaluronidases could be potential targets in the treatment of TED.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Doctoral School of Health Sciences, University of Debrecen, Debrecen, Hungary.
- Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Cite
APA
Papp, F. R., Katko, M., Csiki, R., Galgoczi, E., Molnar, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., & Nagy, E. V. (2024). Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.13.13
Vancouver
Papp FR, Katko M, Csiki R, Galgoczi E, Molnar Z, Erdei A, et al. Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.13.13
BibTeX
@article{Papp2024,
author = {Papp, Fruzsina R and Katko, Monika and Csiki, Robert and Galgoczi, Erika and Molnar, Zsanett and Erdei, Annamaria and Bodor, Miklos and Steiber, Zita and Ujhelyi, Bernadett and Nagy, Endre V},
title = {Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.13.13}
}
EUVIMED